-
Innovation Ranking
NewInnovation Ranking – Ono Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes medicines for the treatment of type II diabetes, overactive bladder, osteoporosis, cancer, chemotherapy-induced nausea and vomiting, osteoporosis, Alzheimer’s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others. The company offers products in various formulations such as capsules, patches, dry syrup, tablets, injections, and intravenous infusions. Ono Pharmaceutical has three manufacturing facilities; Joto Product Development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ONO-7226 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ONO-7226 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ONO-7226 in Solid Tumor Drug Details: The drug candidate is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ONO-7122 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ONO-7122 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ONO-7122 in Solid Tumor Drug Details: ONO-7122 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ONO-4578 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ONO-4578 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ONO-4578 in Gastric Cancer Drug Details: ONO-4578 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ONO-2020 in Neurodegenerative Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ONO-2020 in Neurodegenerative Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ONO-2020 in Neurodegenerative Diseases Drug Details: ONO-2020 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ONO-4685 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ONO-4685 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ONO-4685 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: ONO-4685 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ONO-2808 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ONO-2808 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ONO-2808 in Multiple System...
-
Product Insights
NewNet Present Value Model: Ono Pharmaceutical Co Ltd’s ONO-4686
Empower your strategies with our Net Present Value Model: Ono Pharmaceutical Co Ltd's ONO-4686 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Ono Solar Project
Ono Solar Project is a solar PV project located in Fukushima, Japan. The project is owned and developed by Nippon Renewable Energy KK. The project came online in 2020. Empower your strategies with our Ono Solar Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...